Ole Weis Bjerrum

3.4k total citations
117 papers, 2.4k citations indexed

About

Ole Weis Bjerrum is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Ole Weis Bjerrum has authored 117 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 55 papers in Hematology and 37 papers in Rheumatology. Recurrent topics in Ole Weis Bjerrum's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (52 papers), Eosinophilic Disorders and Syndromes (35 papers) and Chronic Myeloid Leukemia Treatments (23 papers). Ole Weis Bjerrum is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (52 papers), Eosinophilic Disorders and Syndromes (35 papers) and Chronic Myeloid Leukemia Treatments (23 papers). Ole Weis Bjerrum collaborates with scholars based in Denmark, Sweden and Norway. Ole Weis Bjerrum's co-authors include Hans Carl Hasselbalch, Niels Borregaard, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Torben A. Kruse, Mads Thomassen, Vibe Skov, Lars Kjeldsen, Morten K. Jensen and Christen Lykkegaard Andersen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Ole Weis Bjerrum

114 papers receiving 2.4k citations

Peers

Countries citing papers authored by Ole Weis Bjerrum

Since Specialization

Citations

This map shows the geographic impact of Ole Weis Bjerrum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Weis Bjerrum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Weis Bjerrum more than expected).

Fields of papers citing papers by Ole Weis Bjerrum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Weis Bjerrum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Weis Bjerrum. The network helps show where Ole Weis Bjerrum may publish in the future.

Co-authorship network of co-authors of Ole Weis Bjerrum

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Weis Bjerrum. A scholar is included among the top collaborators of Ole Weis Bjerrum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Weis Bjerrum. Ole Weis Bjerrum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The changing landscape of treatment options in childhood acute lymphoblastic leukaemia 2022 ·Drug Discovery Today ·(unknown), Robert Nisticò, (unknown), Ole Weis Bjerrum, (unknown), (unknown), Anthony Serracino‐Inglott, John-Joseph Borg	4
2	The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia 2019 ·The Oncologist ·Sahra Ali, (unknown), Dominik Karres, Justin L. Hay, (unknown), Christian Gisselbrecht, (unknown), Ole Weis Bjerrum, Doris Hovgaard, Yolanda Barbáchano, (unknown), Francesco Pignatti	27
3	Association of the blood eosinophil count with end-organ symptoms 2019 ·Annals of Medicine and Surgery ·Ole Weis Bjerrum, Volkert Siersma, Hans Carl Hasselbalch, Bent Lind, Christen Lykkegaard Andersen	11
4	Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study 2019 ·Haematologica ·Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, (unknown), (unknown), Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch	77
5	Myeloproliferative Neoplasms in Danish Twins 2018 ·Acta Haematologica ·(unknown), Ole Weis Bjerrum, Ajenthen G. Ranjan, Vibe Skov, Torben A. Kruse, Mads Thomassen, Axel Skytthe, Hans Carl Hasselbalch, Kaare Christensen	8
6	The Danish National Chronic Myeloid Neoplasia Registry 2016 ·Clinical Epidemiology ·Marie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, Dorthe Rønnov‐Jessen, Niels Pallisgaard, (unknown), Lene Udby, Hans Carl Hasselbalch, Ole Weis Bjerrum, Christen Lykkegaard Andersen	15
7	A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis 2016 ·PLoS ONE ·Vibe Skov, Mark Burton, Mads Thomassen, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, (unknown), Lasse Kjær, (unknown), (unknown), Mats Ehinger, (unknown), (unknown), Karsten Nielsen, Jürgen Thiele, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch	18
8	Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death 2016 ·Leukemia & lymphoma ·Michael Asger Andersen, Fie Juhl Vojdeman, Mette Klarskov Andersen, Peter de Nully Brown, Christian H. Geisler, Ole Weis Bjerrum, Carsten Utoft Niemann	32
9	Supervised multi-classifier separation of the ph-negative myeloproliferative neoplasms 2015 ·Haematologica ·Vibe Skov, Mark Burton, Mads Thomassen, Thomas Stauffer Larsen, Lasse Kjær, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch	1
10	Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? 2015 ·Gynecologic Oncology ·Christen Lykkegaard Andersen, Christian Winther Eskelund, Volkert Siersma, Peter Felding, Bent Lind, Jan Palmblad, Ole Weis Bjerrum, Søren Friis, Hans Carl Hasselbalch, Niels de Fine Olivarius	11
11	The Copenhagen Primary Care Differential Count (CopDiff) database 2014 ·Clinical Epidemiology ·Christen Lykkegaard Andersen, Volkert Siersma, (unknown), Hans Carl Hasselbalch, Peter Felding, Ole Weis Bjerrum, Niels de Fine Olivarius	15
12	Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation 2014 ·PLoS ONE ·Hans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse	14
13	Haemostasis and Safety Measures before Lumbar Puncture in the Haematology Ward: The Danish Routines 2014 ·Acta Haematologica ·Anders Møller, Ole Weis Bjerrum, Arash Afshari	1
14	Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha 2013 ·Leukemia Research ·Thomas Stauffer Larsen, (unknown), (unknown), Anders Bruun Mathiasen, Claus Werenberg Marcher, Mikael Frederiksen, Herdis Larsen, (unknown), Caroline Hasselbalch Riley, Ole Weis Bjerrum, Dorthe Rønnov‐Jessen, Michael Møller, Karin de Stricker, Hanne Vestergaard, Hans Carl Hasselbalch	71
15	Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis 2012 ·Experimental Hematology ·Vibe Skov, Mads Thomassen, Caroline Hasselbalch Riley, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse, Hans Carl Hasselbalch, Thomas Stauffer Larsen	52
16	Interferon alpha for Treatment of Chronic Myeloid Leukemia 2011 ·Current Drug Targets ·Bengt Simonsson, Henrik Hjorth‐Hansen, Ole Weis Bjerrum, Kimmo Porkka	20
17	Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study 1993 ·European Journal Of Haematology ·Nina Keldsen, Ole Weis Bjerrum, Inger Marie S. Dahl, Aage Drivsholm, Jørgen Ellegaard, Ole Gadeberg, Peter Gimsing, (unknown), Mogens Hansen, Erik Hippe, Jon Lamvik, Bernt Ly, (unknown), Ingebrigt Talstad, K Thorling, (unknown), (unknown)	3
18	Quantitative analysis of phospholipids and demonstration of plasmalogen in human neutrophil subcellular fractions by high-performance liquid chromatography 1989 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Ole Weis Bjerrum, Henrik Nielsen, Niels Borregaard	7
19	Prevention of tissue damage: Inhibition of Myeloperoxidase mediated inactivation of α1 inhibitor by N-acetyl cysteine, Glutathione, and Methionine 1987 ·Inflammation Research ·Niels Borregaard, Hanne Jensen, Ole Weis Bjerrum	23
20	Non‐Hodgkin malignant lymphomas and Hodgkin's disease in first‐degree relatives 1986 ·Scandinavian Journal of Haematology ·Ole Weis Bjerrum, Hans Carl Hasselbalch, Aage Drivsholm, Nis I. Nissen	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact